Literature DB >> 33664351

Polymorphisms of the matrix metalloproteinase genes are associated with essential hypertension in a Caucasian population of Central Russia.

Maria Moskalenko1, Irina Ponomarenko1, Evgeny Reshetnikov2, Volodymyr Dvornyk3, Mikhail Churnosov1.   

Abstract

This study aimed to determine possible association of eight polymorphisms of seven MMP genes with essential hypertension (EH) in a Caucasian population of Central Russia. Eight SNPs of the MMP1, MMP2, MMP3, MMP7, MMP8, MMP9, and MMP12 genes and their gene-gene (epistatic) interactions were analyzed for association with EH in a cohort of 939 patients and 466 controls using logistic regression and assuming additive, recessive, and dominant genetic models. The functional significance of the polymorphisms associated with EH and 114 variants linked to them (r2 ≥ 0.8) was analyzed in silico. Allele G of rs11568818 MMP7 was associated with EH according to all three genetic models (OR = 0.58-0.70, pperm = 0.01-0.03). The above eight SNPs were associated with the disorder within 12 most significant epistatic models (OR = 1.49-1.93, pperm < 0.02). Loci rs1320632 MMP8 and rs11568818 MMP7 contributed to the largest number of the models (12 and 10, respectively). The EH-associated loci and 114 SNPs linked to them had non-synonymous, regulatory, and eQTL significance for 15 genes, which contributed to the pathways related to metalloendopeptidase activity, collagen degradation, and extracellular matrix disassembly. In summary, eight studied SNPs of MMPs genes were associated with EH in the Caucasian population of Central Russia.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33664351      PMCID: PMC7933364          DOI: 10.1038/s41598-021-84645-4

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  53 in total

1.  Association between matrix metalloproteinase gene polymorphisms and development of ischemic stroke.

Authors:  Yunhua Hao; Shihong Tian; Min Sun; Yuanjian Zhu; Zhiyu Nie; Shujuan Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 2.  Reducing Cardiovascular and Cancer Risk: How to Address Global Primary Prevention in Clinical Practice.

Authors:  Allegra Battistoni; Vittoria Mastromarino; Massimo Volpe
Journal:  Clin Cardiol       Date:  2015-04-14       Impact factor: 2.882

Review 3.  Definitions and diagnosis of pulmonary hypertension.

Authors:  Marius M Hoeper; Harm Jan Bogaard; Robin Condliffe; Robert Frantz; Dinesh Khanna; Marcin Kurzyna; David Langleben; Alessandra Manes; Toru Satoh; Fernando Torres; Martin R Wilkins; David B Badesch
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

4.  Impact of hypertension on the lifetime risk of coronary heart disease.

Authors:  Tanvir Chowdhury Turin; Tomonori Okamura; Arfan Raheen Afzal; Nahid Rumana; Makoto Watanabe; Aya Higashiyama; Yoko M Nakao; Michikazu Nakai; Misa Takegami; Kunihiro Nishimura; Yoshihiro Kokubo; Akira Okayama; Yoshihiro Miyamoto
Journal:  Hypertens Res       Date:  2016-03-10       Impact factor: 3.872

5.  Genetic polymorphism of matrix metalloproteinase-1 and coronary artery disease susceptibility: a case-control study in a Han Chinese population.

Authors:  Cui Qintao; Li Yan; Duan Changhong; Guo Xiaoliang; Liu Xiaochen
Journal:  Genet Test Mol Biomarkers       Date:  2014-12

6.  [Polymorphic locus rs1061624 of the ТNFR2 gene is associated with the development of arterial hypertension in males].

Authors:  M I Moskalenko; I V Ponomarenko; S N Milanova; I N Verzilina; O A Efremova; A V Polonikov
Journal:  Kardiologiia       Date:  2020-09-17       Impact factor: 0.395

7.  Imaging Matrix Metalloproteinase Activity Implicated in Breast Cancer Progression.

Authors:  Gregg B Fields; Maciej J Stawikowski
Journal:  Methods Mol Biol       Date:  2016

8.  European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).

Authors:  Joep Perk; Guy De Backer; Helmut Gohlke; Ian Graham; Zeljko Reiner; Monique Verschuren; Christian Albus; Pascale Benlian; Gudrun Boysen; Renata Cifkova; Christi Deaton; Shah Ebrahim; Miles Fisher; Giuseppe Germano; Richard Hobbs; Arno Hoes; Sehnaz Karadeniz; Alessandro Mezzani; Eva Prescott; Lars Ryden; Martin Scherer; Mikko Syvänne; Wilma J M Scholte op Reimer; Christiaan Vrints; David Wood; Jose Luis Zamorano; Faiez Zannad
Journal:  Eur Heart J       Date:  2012-05-03       Impact factor: 29.983

9.  An adaptive permutation approach for genome-wide association study: evaluation and recommendations for use.

Authors:  Ronglin Che; John R Jack; Alison A Motsinger-Reif; Chad C Brown
Journal:  BioData Min       Date:  2014-06-14       Impact factor: 2.522

10.  Diet-Related Risk Factors for Incident Hypertension During an 11-Year Follow-Up: The Korean Genome Epidemiology Study.

Authors:  Hye Ah Lee; Hyesook Park
Journal:  Nutrients       Date:  2018-08-13       Impact factor: 5.717

View more
  3 in total

1.  Maternal polymorphic loci of rs1979277 serine hydroxymethyl transferase and rs1805087 5-methylenetetrahydrofolate are correlated with the development of fetal growth restriction: A case-control study.

Authors:  Olesya Efremova; Irina Ponomarenko; Mikhail Churnosov
Journal:  Int J Reprod Biomed       Date:  2022-01-12

2.  Filaggrin gene polymorphisms are associated with atopic dermatitis in women but not in men in the Caucasian population of Central Russia.

Authors:  Volodymyr Dvornyk; Irina Ponomarenko; Tatyana Belyaeva; Evgeny Reshetnikov; Mikhail Churnosov
Journal:  PLoS One       Date:  2021-12-09       Impact factor: 3.240

3.  Functionally significant polymorphisms of the MMP-9 gene are associated with peptic ulcer disease in the Caucasian population of Central Russia.

Authors:  Oksana Minyaylo; Irina Ponomarenko; Evgeny Reshetnikov; Volodymyr Dvornyk; Mikhail Churnosov
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.